WILSON GLYNN
SEC CIK 1405625 · EDGAR
Most active insiders at CABR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moore Tyler Thomas | CFO | — | — |
| 2 | John Brian | Interim CFO, Dir | — | — |
| 3 | WILSON GLYNN | CEO, Dir, 10% | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-27 | CABR | Caring Brands, Inc. | WILSON GLYNN | CEO, Dir | D - Sale to Iss | $0.5 | -1.50M | 672.6K | -69% | -$750.0K | |
| M | 2025-12-15 | 2025-12-11 | CABR | Caring Brands, Inc. | WILSON GLYNN | CEO, Dir, 10% | A - Grant | $0.00 | -172.6K | 2.17M | -7% | $0 |
| D | 2023-01-24 | 2023-01-24 | CVKD | Cadrenal Therapeutics, Inc. | WILSON GLYNN | Dir | C - Cnv Deriv | — | +50.0K | 50.0K | New | — |
| D | 2022-12-30 | 2022-07-26 | BNKK | BONK, INC. | WILSON GLYNN | CSO, COB, Dir | D - Sale to Iss | — | -14.1K | 950.0K | -1% | — |
| D | 2022-07-27 | 2022-07-26 | BNKK | BONK, INC. | WILSON GLYNN | CSO, COB, Dir | D - Sale to Iss | — | -14.1K | 950.0K | -1% | — |
| 2021-11-15 | 2021-11-10 | BNKK | BONK, INC. | WILSON GLYNN | CSO, COB, Dir | A - Grant | $0.00 | +200.0K | 956.0K | +26% | $0 | |
| D | 2021-08-18 | 2021-08-16 | BNKK | BONK, INC. | WILSON GLYNN | CSO, COB, Dir | A - Grant | $0.00 | +14.1K | 756.0K | +2% | $0 |
| 2021-07-27 | 2021-07-26 | BNKK | BONK, INC. | WILSON GLYNN | CSO, Dir | S - Sale | $2.79 | -50.0K | 750.0K | -6% | -$139.5K |
Purchase Sale Sale after option exercise All abbreviations